FATE1
gene geneOn this page
Also known as FATECT43
Summary
FATE1 (fetal and adult testis expressed 1, HGNC:24683) is a protein-coding gene on chromosome Xq28, encoding Fetal and adult testis-expressed transcript protein (Q969F0). Involved in the regulation of endoplasmic reticulum (ER)-mitochondria coupling.
This gene encodes a cancer-testis antigen that is highly expressed in hepatocellular carcinomas and other tumors and weakly expressed in normal tissues except testis. The protein is strongly expressed in spermatogonia, primary spermatocytes, and Sertoli cells in seminiferous tubules. This protein may have a role in the control of early testicular differentiation and cell proliferation.
Source: NCBI Gene 89885 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 51 total
- MANE Select transcript:
NM_033085
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:24683 |
| Approved symbol | FATE1 |
| Name | fetal and adult testis expressed 1 |
| Location | Xq28 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FATE, CT43 |
| Ensembl gene | ENSG00000147378 |
| Ensembl biotype | protein_coding |
| OMIM | 300450 |
| Entrez | 89885 |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 4 protein_coding
ENST00000370350, ENST00000417321, ENST00000940339, ENST00000940340
RefSeq mRNA: 1 — MANE Select: NM_033085
NM_033085
CCDS: CCDS14700
Canonical transcript exons
ENST00000370350 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000979764 | 151717272 | 151717399 |
| ENSE00000979765 | 151721395 | 151721501 |
| ENSE00000979767 | 151722628 | 151723194 |
| ENSE00001834754 | 151716035 | 151716225 |
| ENSE00003462397 | 151721903 | 151721981 |
Expression profiles
Bgee: expression breadth ubiquitous, 130 present calls, max score 99.25.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.2850 / max 239.0750, expressed in 5 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 197994 | 0.2696 | 4 |
| 197995 | 0.0154 | 3 |
Top tissues by expression
236 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right testis | UBERON:0004534 | 99.25 | gold quality |
| left testis | UBERON:0004533 | 99.09 | gold quality |
| testis | UBERON:0000473 | 97.79 | gold quality |
| adult organism | UBERON:0007023 | 93.43 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 92.07 | gold quality |
| pancreatic ductal cell | CL:0002079 | 82.98 | silver quality |
| adrenal tissue | UBERON:0018303 | 74.11 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 71.15 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 68.57 | gold quality |
| apex of heart | UBERON:0002098 | 65.41 | gold quality |
| ileal mucosa | UBERON:0000331 | 64.97 | silver quality |
| deltoid | UBERON:0001476 | 64.63 | silver quality |
| epithelium of nasopharynx | UBERON:0001951 | 64.20 | gold quality |
| myocardium | UBERON:0002349 | 62.18 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 61.21 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 61.07 | gold quality |
| biceps brachii | UBERON:0001507 | 61.02 | gold quality |
| quadriceps femoris | UBERON:0001377 | 60.69 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 59.46 | gold quality |
| oral cavity | UBERON:0000167 | 59.44 | gold quality |
| parotid gland | UBERON:0001831 | 59.42 | gold quality |
| vastus lateralis | UBERON:0001379 | 59.37 | gold quality |
| skin of hip | UBERON:0001554 | 58.50 | silver quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 58.16 | gold quality |
| gingival epithelium | UBERON:0001949 | 57.70 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 57.20 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 56.72 | silver quality |
| medial globus pallidus | UBERON:0002477 | 56.60 | gold quality |
| mucosa of sigmoid colon | UBERON:0004993 | 56.40 | gold quality |
| decidua | UBERON:0002450 | 55.87 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-134144 | yes | 3978.63 |
| E-GEOD-124263 | yes | 843.59 |
| E-ANND-3 | no | 1.63 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): DNMT3A, NR5A1, STAT4
miRNA regulators (miRDB)
21 targeting FATE1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4725-3P | 99.96 | 69.53 | 2520 |
| HSA-MIR-6780B-5P | 99.96 | 69.60 | 2562 |
| HSA-MIR-1321 | 99.84 | 65.30 | 1811 |
| HSA-MIR-4756-5P | 99.84 | 64.98 | 1809 |
| HSA-MIR-4739 | 99.84 | 65.25 | 1832 |
| HSA-MIR-7106-5P | 99.53 | 67.47 | 3574 |
| HSA-MIR-671-5P | 99.52 | 67.11 | 1277 |
| HSA-MIR-889-5P | 99.41 | 68.75 | 1025 |
| HSA-MIR-6828-5P | 99.31 | 69.21 | 1433 |
| HSA-MIR-4721 | 99.26 | 66.05 | 818 |
| HSA-MIR-6852-5P | 99.17 | 66.69 | 2073 |
| HSA-MIR-3125 | 99.14 | 68.49 | 2269 |
| HSA-MIR-3916 | 98.99 | 68.04 | 2155 |
| HSA-MIR-6859-5P | 98.99 | 68.07 | 2049 |
| HSA-MIR-3154 | 98.94 | 66.55 | 1455 |
| HSA-MIR-219A-1-3P | 98.91 | 67.87 | 639 |
| HSA-MIR-583 | 98.71 | 67.44 | 1791 |
| HSA-MIR-4700-5P | 98.63 | 67.43 | 1915 |
| HSA-MIR-3179 | 98.22 | 65.90 | 1445 |
| HSA-MIR-3192-5P | 96.98 | 65.76 | 1926 |
| HSA-MIR-656-5P | 96.82 | 67.67 | 372 |
Literature-anchored findings (GeneRIF, showing 4)
- This study has shown that only 1.4% of infertile men have mutations in the FATE gene, and that some of these mutations do not singly cause infertility. (PMID:12811541)
- FATE1 is a key survival factor in multiple oncogenic backgrounds. FATE1 prevents the accumulation of the stress-sensing BH3-only protein, BCL-2-Interacting Killer (BIK), thereby permitting viability in the presence of toxic stimuli. (PMID:26567849)
- In patients with ACC, FATE1 expression in their tumor is inversely correlated with their overall survival. the ER-mitochondria uncoupling activity of FATE1 is harnessed by cancer cells to escape apoptotic death and resist the action of chemotherapeutic drugs. (PMID:27402544)
- Study reports that EWSR1-FLI1 directly activates the anomalous expression of FATE1 in Ewing sarcoma. FATE1 is essential for Ewing sarcoma survival through the destabilization of BNIP3L, a poorly characterized BH3-only protein that is toxic to Ewing sarcoma cells. (PMID:31036566)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Fate1 | ENSMUSG00000053593 |
| rattus_norvegicus | ENSRNOG00000066670 |
Protein
Protein identifiers
Fetal and adult testis-expressed transcript protein — Q969F0 (reviewed: Q969F0)
Alternative names: Cancer/testis antigen 43, Tumor antigen BJ-HCC-2
All UniProt accessions (2): Q969F0, H7C1I5
UniProt curated annotations — full annotation on UniProt →
Function. Involved in the regulation of endoplasmic reticulum (ER)-mitochondria coupling. Negatively regulates the ER-mitochondria distance and Ca(2+) transfer from ER to mitochondria possibly implicating it in the regulation of apoptosis. May collaborate with RNF183 to restrain BIK protein levels thus regulating apoptotic signaling.
Subunit / interactions. Interacts with BIK and RNF183. Interacts with IMMT/MIC60and EMD.
Subcellular location. Mitochondrion. Mitochondrion outer membrane. Endoplasmic reticulum membrane.
Tissue specificity. Testis-specific in fetus (aged from 6 to 11 weeks). In adult, expressed predominantly in testis, with some expression in lung, heart, kidney, adrenal gland and whole brain. Highly expressed in certain types of cancer tissues such as hepatocellular carcinoma, colon and gastric cancer. Weakly expressed in normal pancreas.
RefSeq proteins (1): NP_149076* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR039153 | FATE1 | Family |
| IPR039433 | Mff-like_dom | Domain |
Pfam: PF05644
UniProt features (7 total): sequence variant 3, chain 1, transmembrane region 1, region of interest 1, mutagenesis site 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q969F0-F1 | 64.37 | 0.18 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Mutagenesis-validated functional residues (1):
| Position | Phenotype |
|---|---|
| 151 | impairs association with mitochondria. |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 26 (showing top):
GOBP_MITOCHONDRIAL_CALCIUM_ION_HOMEOSTASIS, GOCC_MITOCHONDRIAL_ENVELOPE, GOBP_MONOATOMIC_ION_HOMEOSTASIS, GOCC_ORGANELLE_MEMBRANE_CONTACT_SITE, GOBP_HOMEOSTATIC_PROCESS, GOBP_CHEMICAL_HOMEOSTASIS, GOCC_NUCLEAR_OUTER_MEMBRANE_ENDOPLASMIC_RETICULUM_MEMBRANE_NETWORK, GOCC_ORGANELLE_SUBCOMPARTMENT, GOMF_UBIQUITIN_LIKE_PROTEIN_LIGASE_BINDING, GOCC_ORGANELLE_ENVELOPE, chrXq28, GOCC_MITOCHONDRIA_ASSOCIATED_ENDOPLASMIC_RETICULUM_MEMBRANE_CONTACT_SITE, GSE10500_ARTHRITIC_SYNOVIAL_FLUID_VS_HEALTHY_MACROPHAGE_DN, GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_24H_ACT_CD4_TCELL_UP, GSE12484_HEALTHY_VS_PERIDONTITIS_NEUTROPHILS_UP
GO Biological Process (4): apoptotic process (GO:0006915), negative regulation of apoptotic process (GO:0043066), negative regulation of mitochondrial calcium ion concentration (GO:0051562), regulation of apoptotic process (GO:0042981)
GO Molecular Function (3): ubiquitin protein ligase binding (GO:0031625), identical protein binding (GO:0042802), protein binding (GO:0005515)
GO Cellular Component (7): mitochondrial outer membrane (GO:0005741), endoplasmic reticulum (GO:0005783), endoplasmic reticulum membrane (GO:0005789), mitochondria-associated endoplasmic reticulum membrane contact site (GO:0044233), cytoplasm (GO:0005737), mitochondrion (GO:0005739), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| apoptotic process | 2 |
| cytoplasm | 2 |
| intracellular membrane-bounded organelle | 2 |
| cellular anatomical structure | 2 |
| programmed cell death | 1 |
| apoptotic signaling pathway | 1 |
| execution phase of apoptosis | 1 |
| regulation of apoptotic process | 1 |
| negative regulation of programmed cell death | 1 |
| mitochondrial calcium ion homeostasis | 1 |
| regulation of programmed cell death | 1 |
| ubiquitin-like protein ligase binding | 1 |
| protein binding | 1 |
| binding | 1 |
| mitochondrial membrane | 1 |
| organelle outer membrane | 1 |
| endomembrane system | 1 |
| organelle membrane | 1 |
| nuclear outer membrane-endoplasmic reticulum membrane network | 1 |
| endoplasmic reticulum subcompartment | 1 |
| organelle membrane contact site | 1 |
| intracellular anatomical structure | 1 |
Protein interactions and networks
STRING
592 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| FATE1 | EMD | P50402 | 807 |
| FATE1 | RNF183 | Q96D59 | 747 |
| FATE1 | PROSER2 | Q86WR7 | 659 |
| FATE1 | FMR1NB | Q8N0W7 | 507 |
| FATE1 | SPANXC | Q9NY87 | 506 |
| FATE1 | SPANXD | Q9BXN6 | 506 |
| FATE1 | ZNF165 | P49910 | 478 |
| FATE1 | CD180 | Q99467 | 476 |
| FATE1 | CAV1 | Q03135 | 462 |
| FATE1 | CCDC110 | Q8TBZ0 | 447 |
| FATE1 | XAGE1B | Q9HD64 | 447 |
| FATE1 | CAGE1 | Q8TC20 | 434 |
| FATE1 | YJU2B | P13994 | 406 |
| FATE1 | MYC | P01106 | 404 |
| FATE1 | PACS2 | Q86VP3 | 390 |
IntAct
432 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| EMD | FATE1 | psi-mi:“MI:0915”(physical association) | 0.850 |
| FATE1 | BIK | psi-mi:“MI:0915”(physical association) | 0.830 |
| CCDC70 | FATE1 | psi-mi:“MI:0915”(physical association) | 0.780 |
| FATE1 | NRG4 | psi-mi:“MI:0915”(physical association) | 0.780 |
| INPP5K | FATE1 | psi-mi:“MI:0915”(physical association) | 0.780 |
| FATE1 | CCDC70 | psi-mi:“MI:0915”(physical association) | 0.780 |
| NRG4 | FATE1 | psi-mi:“MI:0915”(physical association) | 0.780 |
| FATE1 | INPP5K | psi-mi:“MI:0915”(physical association) | 0.780 |
| CD79A | FATE1 | psi-mi:“MI:0915”(physical association) | 0.720 |
| SLC7A1 | FATE1 | psi-mi:“MI:0915”(physical association) | 0.720 |
| FATE1 | BNIP2 | psi-mi:“MI:0915”(physical association) | 0.720 |
| FATE1 | BNIP3 | psi-mi:“MI:0915”(physical association) | 0.720 |
| FATE1 | PRRG2 | psi-mi:“MI:0915”(physical association) | 0.720 |
| FATE1 | BCL2L2 | psi-mi:“MI:0915”(physical association) | 0.720 |
| FATE1 | KASH5 | psi-mi:“MI:0915”(physical association) | 0.720 |
| FATE1 | SEC22A | psi-mi:“MI:0915”(physical association) | 0.720 |
| FATE1 | SEC22C | psi-mi:“MI:0915”(physical association) | 0.720 |
BioGRID (150): FATE1 (Two-hybrid), FATE1 (Two-hybrid), FATE1 (Two-hybrid), FATE1 (Two-hybrid), FATE1 (Two-hybrid), FATE1 (Two-hybrid), FATE1 (Two-hybrid), FATE1 (Two-hybrid), FATE1 (Two-hybrid), FATE1 (Two-hybrid), FATE1 (Two-hybrid), FATE1 (Two-hybrid), FATE1 (Two-hybrid), FATE1 (Two-hybrid), FATE1 (Two-hybrid)
ESM2 similar proteins: A0A0P0WFC8, A1L1K1, A2APA5, A2ARM1, A2AVJ5, A5A777, A5WV69, A7YY97, D1FP57, D3ZR35, E9Q942, H3BTG2, O15482, O82259, P14232, P59773, Q08176, Q14CH0, Q2KHT9, Q2KIK3, Q2T9Z2, Q39162, Q39237, Q498C7, Q4V9P3, Q5E9R0, Q5EB20, Q5FVH8, Q5RA87, Q5XIC3, Q6GPM0, Q6MZQ0, Q6P566, Q6P995, Q751Y8, Q7L3B6, Q8AWD1, Q8BQP9, Q8CEK7, Q8N0W7
Diamond homologs: Q3ZCD8, Q4KM98, Q503U3, Q5R795, Q6DD53, Q6GQI8, Q6PCP5, Q7SZQ4, Q969F0, Q9GZY8, Q8CEK7, Q95LA0, Q95LB4
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
51 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 31 |
| Likely benign | 5 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
830 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| X:151716219:A:AG | donor_gain | 1.0000 |
| X:151716222:GCAG:G | donor_gain | 1.0000 |
| X:151716224:AGGT:A | donor_loss | 1.0000 |
| X:151716226:G:GA | donor_loss | 1.0000 |
| X:151716226:G:GG | donor_gain | 1.0000 |
| X:151721393:AG:A | acceptor_gain | 1.0000 |
| X:151721393:AGG:A | acceptor_gain | 1.0000 |
| X:151721394:GG:G | acceptor_gain | 1.0000 |
| X:151721394:GGG:G | acceptor_gain | 1.0000 |
| X:151721480:GCA:G | donor_gain | 1.0000 |
| X:151721901:A:AG | acceptor_gain | 1.0000 |
| X:151721902:G:GT | acceptor_gain | 1.0000 |
| X:151721902:GC:G | acceptor_gain | 1.0000 |
| X:151721902:GCA:G | acceptor_gain | 1.0000 |
| X:151721902:GCAA:G | acceptor_gain | 1.0000 |
| X:151721902:GCAAC:G | acceptor_gain | 1.0000 |
| X:151721904:A:AG | acceptor_gain | 1.0000 |
| X:151721905:A:G | acceptor_gain | 1.0000 |
| X:151721964:G:GT | donor_gain | 1.0000 |
| X:151721977:GACAG:G | donor_gain | 1.0000 |
| X:151721982:G:GG | donor_gain | 1.0000 |
| X:151722563:T:TA | acceptor_gain | 1.0000 |
| X:151722627:GCT:G | acceptor_gain | 1.0000 |
| X:151722627:GCTGT:G | acceptor_gain | 1.0000 |
| X:151717270:A:AG | acceptor_gain | 0.9900 |
| X:151717271:G:GG | acceptor_gain | 0.9900 |
| X:151717271:GA:G | acceptor_gain | 0.9900 |
| X:151717271:GAA:G | acceptor_gain | 0.9900 |
| X:151717271:GAAAT:G | acceptor_gain | 0.9900 |
| X:151717398:TGG:T | donor_loss | 0.9900 |
AlphaMissense
1190 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| X:151722724:A:C | S173R | 0.977 |
| X:151722726:C:A | S173R | 0.977 |
| X:151722726:C:G | S173R | 0.977 |
| X:151722629:T:C | L141P | 0.942 |
| X:151722722:C:A | A172D | 0.937 |
| X:151722650:T:C | L148P | 0.936 |
| X:151722739:T:A | W178R | 0.926 |
| X:151722739:T:C | W178R | 0.926 |
| X:151722731:C:A | A175D | 0.922 |
| X:151722647:G:C | R147P | 0.896 |
| X:151722707:C:A | A167D | 0.896 |
| X:151722662:A:T | E152V | 0.890 |
| X:151722737:T:C | L177P | 0.884 |
| X:151722716:T:A | V170E | 0.883 |
| X:151722735:C:A | N176K | 0.874 |
| X:151722735:C:G | N176K | 0.874 |
| X:151722713:T:G | L169R | 0.870 |
| X:151722743:T:C | L179P | 0.865 |
| X:151721959:A:T | E133V | 0.863 |
| X:151722710:T:A | V168E | 0.859 |
| X:151722728:T:A | I174N | 0.858 |
| X:151721980:A:C | Q140P | 0.850 |
| X:151722659:T:C | L151P | 0.846 |
| X:151722655:G:C | A150P | 0.840 |
| X:151722663:G:C | E152D | 0.839 |
| X:151722663:G:T | E152D | 0.839 |
| X:151722721:G:C | A172P | 0.835 |
| X:151722745:T:A | W180R | 0.833 |
| X:151722745:T:C | W180R | 0.833 |
| X:151722692:A:T | E162V | 0.827 |
dbSNP variants (sampled 300 via entrez): RS1000098596 (X:151719180 G>A), RS1000566062 (X:151716767 C>T), RS1001411260 (X:151720117 G>A), RS1002080607 (X:151717494 C>A,T), RS1002290591 (X:151718413 A>G), RS1002492191 (X:151717968 C>G), RS1003697297 (X:151719464 C>T), RS1003745136 (X:151719967 A>G), RS1003813022 (X:151718219 G>A), RS1003906009 (X:151718602 T>C), RS1004798714 (X:151716365 T>C), RS1004934329 (X:151716718 C>A,T), RS1005797727 (X:151715730 C>G), RS1006161214 (X:151715431 G>T), RS1006219046 (X:151722489 C>T)
Disease associations
OMIM: gene MIM:300450 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST008887_8 | Systemising | 1.000000e-06 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0010221 | systemising measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
9 total (human), top 9 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sotorasib | affects cotreatment, increases expression | 1 |
| sodium arsenite | increases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| trametinib | affects cotreatment, increases expression | 1 |
| NVP-BKM120 | affects cotreatment, increases expression | 1 |
| Decitabine | increases expression | 1 |
| Benzo(a)pyrene | affects methylation, increases methylation | 1 |
| Valproic Acid | decreases methylation | 1 |
| Aflatoxin B1 | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.